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Abstract Herpes simplex virus type 1 (HSV-1) is a neuro-
tropic virus linked to a range of acute and chronic neurological
disorders affecting distinct regions of the brain. Unusually,
HSV-1 entry into cells requires the interaction of viral proteins
glycoprotein D (gD) and glycoprotein B (gB) with distinct
cellular receptor proteins. Several different gD and gB recep-
tors have been identified, including TNFRSF14/HVEM and
PVRL1/nectin 1 as gD receptors and PILRA, MAG, and
MYH9 as gB receptors. We investigated the expression of
these receptor molecules in different areas of the adult and
developing human brain using online transcriptome data-
bases. Whereas all HSV-1 receptors showed distinct expres-
sion patterns in different brain areas, the Allan Brain Atlas
(ABA) reported increased expression of both gD and gB re-
ceptors in the hippocampus. Specifically, for PVRL1,
TNFRFS14, and MYH9, the differential z scores for hippo-
campal expression, a measure of relative levels of increased
expression, rose to 2.9, 2.9, and 2.5, respectively, comparable
to the z score for the archetypical hippocampus-enriched min-
eralocorticoid receptor (NR3C2, z = 3.1). These data were
confirmed at the Human Brain Transcriptome (HBT) data-
base, but HBT data indicate that MAG expression is also
enriched in hippocampus. The HBT database allowed the de-
velopmental pattern of expression to be investigated; we re-
port that all HSV1 receptors markedly increase in expression
levels between gestation and the postnatal/adult periods.
These results suggest that differential receptor expression
levels of several HSV-1 gD and gB receptors in the adult
hippocampus are likely to underlie the susceptibility of this
brain region to HSV-1 infection.
Keywords HSV-1 . Brain . Hippocampus . Virus receptor .
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Introduction
Infection with herpes simplex virus type 1 and 2 (HSV-1/2)
causes orofacial, genital, cerebral, and ocular disorders. In
particular, HSV-1 has been implicated in diverse acute and
chronic neurological diseases including meningitis, encepha-
litis, and epilepsy (Gilden et al. 2007; Kleinschmidt-
DeMasters and Gilden 2001).
Herpesviruses are thought to enter the brain via the olfac-
tory pathway, as argued for HSV-1 (Mori et al. 2005) and
other neurotropic viruses (Harberts et al. 2011), and then mi-
grate to linked susceptible regions. HSV meningitis typically
affects the temporal cortex, and infection of the limbic system
including the hippocampus (Hpc) is implicated in HSV-1 en-
cephalitis (Damasio and Van Hoesen 1985). Epilepsy associ-
ated with HSV-1 may also involve the Hpc because origins of
focal epilepsy are typically found in the temporal lobe
(reviewed in Blair 2012). An immunological study reported
the presence of HSVantigen within temporal lobe and Hpc of
human herpes encephalitis, with further evidence for antigen
in amygdala and olfactory cortex (Esiri 1982). In mouse, in-
oculation of HSV into Hpc gave significantly more severe
disease than inoculation into cerebellum (McFarland and
Hotchin 1987). However, the tropism of HSV for the temporal
brain remains unexplained.
A major factor determining species and tissue specificity of
viruses is the cellular receptor(s) mediating viral entry. In
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contrast to most other viruses, HSV-1 entry into epithelial or
neuronal cells is a complex process requiring multiple viral
glycoproteins and cellular receptor molecules, including the
four viral glycoproteins, glycoprotein D (gD), glycoprotein B
(gB), glycoprotein H (gH), and glycoprotein L (gL), as well as
the cellular receptors for at least gD and gB. Entry involves a
series of concerted events based on the interaction between
ligands and receptors that eventually lead to fusion of the viral
and cellular membranes (Campadelli-Fiume et al. 2012a). The
initial step of HSV-1 entry is low-affinity attachment of viral
particles to cell-surface heparan sulfate proteoglycans
(HSPGs) via gH and gB. HSPGs are very widely expressed
by a broad range of different cells including neurons. This
initial attachment is followed by high-affinity binding of the
viral gD glycoprotein to one of the gD receptors, either polio-
virus receptor-like protein 1 (PVRL1, also known as nectin 1)
or tumor necrosis factor (TNF) receptor superfamily member
14 (TNFRSF14), also known as herpesvirus entry mediator
(HVEM). In mouse, PVRL1 knockout was reported to atten-
uate but not abolish HSV infection (Taylor et al. 2007), and
PVRL1 was essential for lethal brain infection when inoculat-
ed directly (Kopp et al. 2009), but not peripherally. By con-
trast, TNFRSF14 (HVEM) was not essential (Kopp et al.
2009). The current view is that receptor-bound gD leads to
activation of gH/gL, which in turn transforms gB into a
fusion-competent state (Campadelli-Fiume et al. 2012a).
Virus-induced membrane fusion, however, is only possible if
gB is bound by an additional specific gB receptor. Three gB
receptors are currently known, including (i) the paired
immunoglobulin-like type 2 receptor α (PILRA), (ii) another
paired-type receptor with homology to PILRA, myelin-
associated glycoprotein (MAG), and (iii) myosin heavy chain
9 (MYH9, non-muscle, also known as NMMHC-IIA). There
is also some evidence that HSV-1 entry may require the bind-
ing of the gH/gL heterodimer to a cellular receptor
(Campadelli-Fiume et al. 2012b; Karasneh and Shukla 2011).
In vitro, HSV-1 infects a diverse spectrum of different hu-
man and non-human cells. In vivo, however, infection is much
more restricted to epithelial and neuronal cells. Despite exten-
sive characterization of HSV-1 receptors, little is known about
their tissue expression patterns in the human brain. In mouse,
PVRL1/nectin 1 expression has been reported in limbic re-
gions, frontal association cortex, and olfactory system (e.g.,
Horvath et al. 2006), but few studies are available in human.
Guzman et al. (2006) and Geraghty et al. (1998) reported
expression of PVRL1/nectin 1 in a variety of normal and
transformed human cells, but the brain distribution was not
analyzed. In the most detailed study of human brain,
Prandovszky et al. (2008) used immunohistochemistry to in-
spect fetal human tissues and reported PVRL1 expression in
endometrium, cornea, and cortex, with strong staining in py-
ramidal cells of the Hpc. However, no studies have addressed
the expression of HSV-1 receptors other than PVRL1 in
human brain. In mice, there are marked changes in receptor
expression between the fetal and postnatal periods (Horvath
et al. 2006; Prandovszky et al. 2008), but the patterns of HSV-
1 receptor expression in adult human brain have not been
examined. We therefore used different online transcriptome
databases to map the expression patterns of all known HSV-
1 gD and gB receptors in adult and developing human brain.
Methods
HSV-1 receptor genes
The following HSV-1 receptor genes were used in this study:
PVRL1 (NM_002855), TNFRSF14 (NM_001297605),
PILRA (NM_013439), MYH9 (NM_002473), and MAG
(NM_001199216). As a positive control gene for the limbic
brain, we used the mineralocorticoid receptor NR3C2
(NM_000901) that is selectively expressed in the Hpc. The
housekeeping gene glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) (NM_001256799) was used as a reference
control. Where GAPDH data were not available, GAPDH2/
GAPDHS (NM_014364) was employed instead.
Extraction of expression profiling data
Expression profiling results were first extracted from the
microarray-based Allen Human Brain Atlas (ABA; v.1
March 2013; brainmap.org) of human brain gene expression
(Hawrylycz et al. 2012) using the syntax GENE1ORGENE2.
The database is generally based on at least two probes per
gene and brain samples from six individuals. The ABA
heatmap image was toggled to align all results by region; the
image and associated z score data were downloaded. To eval-
uate fold changes in expression levels, the ABA human gene
database was interrogated in differential mode for Hpc versus
a control brain tissue, cerebellum. For developmental expres-
sion profiling, the microarray-based Human Brain
Transcriptome database (consulted August 2016;
http://hbatlas.org/pages/hbtd) was employed. Expression
levels (log2 values) at different developmental stages were
calculated from the trendline presented for each gene; each
point is dependent on at least three independent
measurements for a single hybridization probe. Bodywide
expression profiles were determined from https://www.ncbi.
nlm.nih.gov/geoprofiles, https://www.ebi.ac.uk/gxa/home,
and http://biogps.org.
Data analysis and statistics
Primary ABA z scores were imported into OpenOffice (www.
openoffice.org) spreadsheets for analysis and graphical plots.
Normalized expression profiling results with positive z scores
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were presented as a heatmap with black (z = 0, no difference
frommean), dark red (z = +1, 1 × SD above mean), and bright
red (z = +2, 2 × SD above mean). For numeric fold change
data, Hpc gene expression was compared to cerebellum, and
data for 29,509 probes were downloaded as batches of 2000
rows including P values and fold changes and searched
manually for the listed HSV-1 receptor genes (for details of
computations see brainmap.org). For the HBT data, log2
values were converted to absolute values before calculation
of means and SD; P values for Hpc versus neocortex and
cerebellum employed the Student t test.
Results
Expression in adult human brain
Currently, both glycoprotein D (gD) and group glycoprotein B
(gB) receptors are known to be essential for HSV-1 viral entry
(Table 1). To address their distribution in adult human brain,
we extracted the expression profiles as z scores (see
BMethods^ section) from the microarray-based Allen Brain
Atlas (ABA) gene expression database of adult human brain
(Hawrylycz et al. 2012). Controls were housekeeping gene
GAPDH and the Hpc-selective gene NR2C3 (mineralocorti-
coid receptor). In Fig. 1a, the z scores for HSV-1 gD and gB
receptors are plotted across the human brain, and Fig. 1b
shows their distribution in the telencephalon.
Some brain regions were found to express only one type of
receptor. For example, the cerebellum (*) expresses elevated
levels of the gB receptor gene PILRA, but this was not accom-
panied by elevated levels of gD receptor gene expression. Two
brain regions, however, show a highly significant (z = >2.0)
enrichment for the expression of both types of HSV-1 recep-
tors—the Hpc (region 1 in Fig. 1) and the choroid plexus (CP,
region 11) of the lateral ventricle, which lies in close proximity
to the Hpc. These two regions prominently express genes for
both gD (PVRL1 and TNFRSF14) and gB (MYH9) HSV-1
receptors. By contrast, no enriched expression of GAPDH
was observed (z = 0.0), whereas the positive control,
NR2C3, was strongly and selectively expressed in Hpc as
expected (z = 3.1).
In addition to the Hpc and the choroid plexus, several re-
gions (2–10 in Fig. 1) such as the globus pallidus (Gp, 2)
display elevated but less-pronounced (z ≥ 1.0) expression of
both gD and gB receptors, predominantly PVRL1 and MAG.
We also comparedHSVreceptor profiles betweenmale and
female brain. Overall, the patterns were highly similar, with
selective Hpc expression in both male and female, and close
inspection revealed no major differences, although potential
differential receptor expression was noted in two regions: the
choroid plexus, where high-level expression was present in
male but not female, and the lateral hypothalamic area (ante-
rior region), where expression was elevated in female but not
in male (data not presented). However, because the ABA mi-
croarray profiles are based on a single female individual, no
firm conclusions may be drawn.
To obtain an estimate of the actual level of overexpression
of these receptors in Hpc, the ABA gene expression database
was interrogated in differential mode in which Hpc was com-
pared against a control brain region, the cerebellum. As shown
in Table 2, the positive control NR3C2 is overexpressed by a
factor of 3.25, whereas the housekeeping control showed no
overexpression (1.04). The three key HSV-1 receptor genes,
Table 1. Known gD and gB receptors for HSV-1
Receptor Gene/protein
symbol
Aliases Protein Family Tissue expressiona
gD receptors
Tumor necrosis factor receptor
superfamily, member 14
(herpesvirus entry mediator,
HVEM)
TNFRSF14 ATAR, CD270, HVEA, HVEM,
LIGHTR, TR2
TNF receptor superfamily Immune cells, broadly
expressed
Poliovirus receptor-like 1
(herpesvirus entry mediator C)
PVRL1 NECTIN1, CD111, CLPED1,
ED4, HIgR, HVEC, OFC7,
PRR, PRR1, PVRR, SK-12
Immunoglobulin
superfamily
Epithelial cells, broadly
expressed
gB receptors
Paired immunoglobulin-like
type 2 receptor α
PILRA FDF03 Immunoglobulin
superfamily
Gastrointestinal tract,
genital tract, lung
Myelin-associated glycoprotein MAG GMA, SIGLEC-4A, S-MAG Myelin protein family Brain
Myosin heavy chain 9,
non-muscle
MYH9 DFNA17, FTNS, EPSTS,
NMMHC-IIA
Myosin protein family Bone marrow, lung, GI
tract, genital tract
a Bodywide tissue distribution profiles were determined using publicly available databases at https://www.ncbi.nlm.nih.gov/geoprofiles, https://www.
ebi.ac.uk/gxa/home, and http://biogps.org
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MYH9, PVRL1, and TNFRSF14, were 2.07-, 3.06-, and 1.84-
fold overexpressed in Hpc, respectively (P < 0.001 in all
cases) (Table 2).
We also consulted the ABA to compare human versus
mouse brain profiles of HSV receptor expression. Although
the small size of the mouse brain does not lend itself to accu-
rate interrogation of gene expression patterns in specific sub-
structures (e.g., brainstem nuclei), this analysis confirmed
enriched expression of Myh9 (gB) and Pvrl1 (gD) in Hpc, in
accordance with previous data for Pvrl1 (BIntroduction^
section). Mouse data for Tnfrs14 were not reliable, and for
Pilra, no overexpression in cerebellum was present (data not
presented), in contrast to the situation for human. Overall, we
conclude that enriched expression of HSV receptors in adult
Hpc is a feature of both mouse and human.
Developmental profile of HSV-1 receptor expression
There are marked changes in mouse brain expression profiles
between gesta t ional and postnata l /adul t per iods
Fig. 1. Distribution of HSV-1 gD and gB receptor expression across a
the whole human brain and b telencephalon (data: Allan Brain Atlas).
Brain regions (numbered) are 1 hippocampus, Hpc; 2 globus pallidus; 3/4
subthalamus, lateral and geniculate nuclei; 5 ventral thalamus; 6 red
nucleus; 7 dentate/fastigial/globose nuclei; 8 superior olivary complex
and trigeminal nuclei; 9/10 cuneate/dorsal motor/gracile/vestibular
nuclei and corpus callosum; 11 choroid plexus of the lateral ventricle.
Asterisk, cerebellum, high expression of PILRA (gB) but low
expression of gD receptors. The positive control for region-specific
expression was NR3C2 (mineralocorticoid receptor); the housekeeping
gene control was glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The lower panel in a gives the plotted mean z scores for
PVRL1 + TNFRSF14 + MYH9 (negative scores not presented); the
lower panel in b gives the individual z scores for PVRL1, TNFRSF14,
and MYH9
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(BIntroduction^ section). To address the developmental profile
of human HSV-1 receptors, we consulted the Human Brain
Transcriptome (HBT) database (Johnson et al. 2009; Kang
et al. 2011). This also provided independent verification of
results generated by ABA. HBT data are for a range of ages,
but for a restricted number of brain regions, and to simplify
analysis, we focused on five developmental stages as follows:
140 days (mid-gestation), 655 days (1 year postnatal),
2000 days (4.7 years, child), 10,000 days (26.6 years, adult),
and 30,000 days (81.4 years, elderly). We also focused on
three specific brain regions: Hpc (in which enrichment of
HSV receptors in adult brain was indicated, see earlier); neo-
cortex (NCX, another telencephalon region, cf. Fig. 1b); and
cerebellar cortex (CB, control for differential overexpression
calculations, cf. Table 2). Because the HBT analysis is based
on a commercial chip, data for the housekeeping control
GAPDH were unavailable; GAPDH2 (also known as
GAPDHS) was used instead. In addition, no data were avail-
able for TNFRSF14.
The results (Fig. 2) confirmed marked developmental
changes in the levels of expression of the HSV-1 receptors
analyzed. Overall, expression was much lower during gesta-
tion than in postnatal life, with major upregulation taking
place between mid-gestation and 1 year of age for MAG and
MYH9. For MAG, MYH9, and PVRL1, overall expression
levels averaged across all ages were significantly higher in
Hpc than in cerebellum, in agreement with our results obtain-
ed from adult human brain (this work) and with a previous
report of enriched PVRL1 expression in Hpc of fetal brain
(Prandovszky et al. 2008). Mean fold overexpression levels
(Hpc versus cerebellum) across all ages were 2.90, 1.74, and
1.45 for MAG, MYH9, and PVRL1, respectively (values for
adult only are given in Table 2); fold overexpression for
NR3C2 (all ages) was 2.72, whereas the housekeeping control
showed no enrichment (1.02-fold).
For PILRA, in confirmation of Fig. 1 data, adult cerebellar
expression levels were significantly higher than in Hpc, but
this was only seen later in development, and in mid-gestation
levels were uniformly low.
A major discrepancy between ABA and HBT emerged,
with high levels of MAG expression being seen in postnatal
Hpc in the HBT database, whereas these regions were not
enriched over mean brain levels in ABA. Although less au-
thoritative than either ABA or HBT, Caracausi and co-
workers report no enrichment of MAG expression in human
Hpc (Caracausi et al. 2016), supporting ABA. However, a
question mark remains regarding whether MAG is expressed
selectively in the Hpc versus other brain regions.
In summary, this analysis confirms enriched expression in
Hpc for three HSV-1 receptor genes, MYH9 (gB receptor),
PVRL1 (gD), and TNFRSF14 (gD), whereas data for MAG
(gB) were discordant, but possibly also pointing to enriched
Table 2. Relative transcript
levels of HSV-1 receptors in adult
human hippocampus versus
cerebellum
Database ABA HBT
Gene Fold change scorea Mean fold change P valuea Mean fold changeb P valueb
Controls
NR3C2 3.33c 3.25 8.21E−80 1.85 <0.001
3.17c 1.53E−74
GAPDH 1.04 1.04 ns nd na
GAPDH2 na na na 0.98 ns
HSV receptors
MAG ne ne na 2.90 <0.001
MYH9 2.15 2.07 1.92E−44 1.99 <0.001
1.98 5.01E−57
PILRA ne ne na ne na
PVRL1 4.04 3.06 1.11E−46 1.40 <0.001
2.59 5.62E−38
2.54 4.55E−38
TNFRSF14 2.49 1.84 4.39E−56 nd nd
1.18 5.84E−03
ABA Allan Brain Atlas, HBT Human Brain Transcriptome database, na not applicable, nd no data, ns not
significant, ne not enriched in hippocampus
a Fold change overexpression scores were determined by comparing levels of gene expression in Hpc versus a
control brain region (cerebellum, Cb); P values and fold change scores were computed online at ABA
b Fold change overexpression scores are for adult Hpc versus cerebellar cortex and are means of values for age-
points 10,000 days (adult) and 30,000 days only (elderly adult); P values for Hpc versus cerebellar cortex, Student
t test
c Different entries for each gene correspond to different hybridization probes for the same target (cf Fig. 1)
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expression in Hpc. By contrast, PILRA1 (gB) was promi-
nently expressed in cerebellum. In all cases, there was a
marked increase in expression levels between gestation and
postnatal life.
Discussion
Type 1 herpes simplex virus (HSV-1) is a neurotropic virus
that affects select brain regions including particular brainstem
nuclei and, most notably, the temporal brain including the
Hpc, both in mouse and in human. HSV-1 is unusual among
viruses in that it requires the expression of two different re-
ceptors on the same target cell, which respectively interact
with viral glycoproteins gB and gD (BIntroduction^ section).
We present for the first time a systematic analysis of the dis-
tribution of both gB and gD HSV-1 receptors in human brain.
Our results confirm and extend previous results, in mouse, that
the gene encoding the HSV-1 receptor PVRL1 is selectively
expressed in Hpc (Horvath et al. 2006), and we now report
that, in adult human, at least three HSV-1 receptors are differ-
entially expressed in Hpc,MYH9 (gB receptor), PVRL1 (gD),
and TNFRSF14 (gD), whereas PILRA (gB) is most abundant-
ly expressed in human cerebellum. For MYH9, PVRL1, and
TNFRSF144, the level of upregulation in Hpc was comparable
to that observed for the mineralocorticoid receptor, the
archetypical Hpc-specific transcript in mouse (discussed be-
low).MAG (gB) expression may also be enriched in Hpc, but
there was major discrepancy between the two databases we
consulted (ABA and HBT), with high levels of MAG expres-
sion being seen in postnatal Hpc in the HBT database, where-
as this region was not apparently enriched over mean brain
levels in ABA. We have no explanation for this result, but
possible explanations include the use of different hybridiza-
tion probes that might detect alternative transcript splicing
and/or differential background hybridization, noting that
ABA is in general based on two or more probes per gene,
whereas HBT relies on single probes.
Although the different human brains sampled in ABA gave
slightly different expression patterns for the same hybridiza-
tion target, in this study the overall profile was largely con-
served (Fig. 1); technical issues with tissue preparation com-
bined with genetic and environmental effects may underlie
this variability.
In addition, patterns were substantially conserved between
male and female brain, with selective HSV receptor expres-
sion in Hpc in both male and female. There were potentially
some minor differences (BResults^ section); however, the
ABA microarray database is based on a single female individ-
ual, and studies on a greater diversity of individuals will be
necessary to address possible male/female differences in HSV
receptor expression.
Fig. 2. Developmental profiling
of HSV-1 receptor expression (log
scale) in three different brain
regions and across five
developmental stages (data:
Human Brain Transcriptome).
Abbreviations: CB cerebellar
cortex, HPC hippocampus, NCX
neocortex. No data for
TNFRSF14 were available.
NR3C2 (mineralocorticoid
receptor), positive control for
hippocampal expression;
GAPDH2, housekeeping control.
P values: Student t test
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Both databases confirm that PILRA (gB receptor) is prom-
inently expressed in cerebellum; however, there was no paral-
lel enrichment of gD receptors: lack of gD receptors could
explain the observation, in mouse, that inoculation of HSV
into cerebellum did not give rise to severe disease
(McFarland and Hotchin 1987).
Significant gB/gD receptor expression was also observed
(ABA) in adult globus pallidus (Gp), trigeminal nuclei,
brainstem, and red nucleus. This is of interest because HSV-1
brain infection can sometimes selectively involve the Gp (Hu
et al. 2003). The trigeminal nuclei are also of note because they
are connected to the trigeminal ganglia where HSV-1 latently
persists (Baringer and Swoveland 1973; Croen et al. 1987;
Furuta et al. 1992; Theil et al. 2001), and selective involvement
of the brainstem in some cases of HSV-1 encephalitis has been
reported (Livorsi et al. 2010). Finally, the presence of receptors
in the red nucleus is notable because this region is functionally
connected with the Hpc (Dypvik and Bland 2004; Nioche et al.
2009). The relevance of other brain regions highlighted in
Fig. 1 to the pathobiology of HSV-1 infection is not known
and warrants further investigation.
The finding that HSV-1 receptors are expressed at only low
levels in gestation, but rise markedly during the postnatal pe-
riod, is notable because the fetal human brain is not generally
subject to infection with HSV-1, in contrast to other viruses
(e.g., cytomegalovirus, rubella, Zika virus) that can establish
damaging brain infection during gestation (Driggers et al.
2016; Guillemette-Artur et al. 2016; McCarthy et al. 2011;
Naeye and Blanc 1965). Although exposed to HSV-1 in utero
of HSV-1-positive mothers, overt pathology appears to be
generally limited to postnatal ages. Our results suggest that
the fetal human brain may be partially refractory to HSV-1
infection owing to low levels of receptor expression.
This study has some limitations. First, the data presented
address transcript levels rather than protein expression. Brain
proteomic analysis demonstrates expression of PVRL1 in
adult human Hpc (Hondius et al. 2016), but other brain
regions were not studied; comprehensive proteomics of hu-
man brain (an emerging project at www.hupo.org/human-
brain-proteome-project) will be necessary to confirm the
regional distribution of HSV-1 receptors. Second, cell-
surface receptors are not the only determinants of virus tro-
pism, and multiple levels of control on virus entry, genome
transcription, and translation govern the outcome of infec-
tion. Additional restriction factors include routing factors
such as αVβ3 integrin (Campadelli-Fiume et al. 2012a),
which affect virus internalization, and also proteins such as
B5 that influence HSV-1 translation (Cheshenko et al. 2010;
Perez et al. 2005). However, without expression of receptors
for both gD and gB, effective virus entry cannot take place.
Third, much of our analysis addresses the normalized z score
or fold-change values instead of absolute expression levels.
However, this is not necessarily misleading. To illustrate,
mineralocorticosteroids are known to selectively target the
Hpc, and, for the mineralocorticoid receptor NR3C2, the
top-ranked gene for selective expression in mouse Hpc
(Lein et al. 2007), both the z and fold change scores were
comparable to those generated by both gD and gB receptors
(Fig. 1 and Table 2).
Further, because HSV-1 entry requires the simultaneous
expression of at least two different receptors, conjoint over-
representation of both receptor types in a single tissue even by
a small amount may be anticipated to synergistically and dis-
proportionately influence the statistical likelihood of encoun-
tering both types of receptor on the same cell, further ampli-
fied during serial transfer between cells, and thus favor selec-
tive tissue tropism. For example, if there is only a 2-fold ex-
cess of receptors for gB (MYH9) and gD (PVRL1 plus
TNFRSF14), the differential efficiency of primary infection
could rise 8×, and to 64× for a further round of infection.
In conclusion, the selective virus receptor gene expression
profiles reported here may contribute to the tropism of HSV-1
for particular postnatal brain regions in human, centrally in-
cluding the temporal brain and Hpc.
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